|
|
|
|
|||||
|
|
|
NORTH CHICAGO, Ill., Feb. 24, 2026 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the TD Cowen 46th Annual Health Care Conference on Tuesday, March 3, 2026. Management will participate in a fireside chat at 10:10 a.m. Central Time.
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Media: Gabby Tarbert (224) 244-0111 | Investors: Liz Shea |
SOURCE AbbVie
| Feb-27 | |
| Feb-26 | |
| Feb-25 | |
| Feb-25 | |
| Feb-25 | |
| Feb-25 | |
| Feb-25 | |
| Feb-24 | |
| Feb-24 | |
| Feb-24 | |
| Feb-24 | |
| Feb-24 | |
| Feb-24 | |
| Feb-24 |
AbbVie announces $380m investment in North Chicago API facilities
ABBV
Pharmaceutical Business Review
|
| Feb-24 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite